BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7691445)

  • 1. "Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites.
    Chen PH; Lin SY; Wang CK; Chen YJ; Chen TC; Chang JG
    Clin Chem; 1993 Oct; 39(10):2186-91. PubMed ID: 7691445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of K-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method.
    Lin SY; Chen PH; Wang CK; Liu JD; Siauw CP; Chen YJ; Yang MJ; Liu MH; Chen TC; Chang JG
    Am J Clin Pathol; 1993 Dec; 100(6):686-9. PubMed ID: 8249918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of beta-thalassemia mutations in Chinese by naturally and amplified created restriction sites.
    Chang JG; Chen PH; Chiou SS; Lee LS; Perng LI; Liu TC
    Blood; 1992 Oct; 80(8):2092-6. PubMed ID: 1391961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using biopsy materials to detect mutations in gastrointestinal tumors.
    Hosoi H; Hirosawa S; Yamamoto K; Ohkusa T; Aoki N
    J Clin Gastroenterol; 1995 Jun; 20(4):272-6. PubMed ID: 7665812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A molecular pathological study of p53 gene in hepatocellular carcinoma].
    Zhao P
    Zhonghua Bing Li Xue Za Zhi; 1993 Feb; 22(1):16-8. PubMed ID: 8101139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
    Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
    Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA.
    Lohmann DR; Funk A; Niedermeyer HP; Häupel S; Höfler H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(5):293-6. PubMed ID: 8287125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
    Lasky T; Silbergeld E
    Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of mutations induced in vitro in the human p53 gene by hydrogen peroxide with the restriction site mutation (RSM) assay.
    Jenkins GJ; Morgan C; Baxter JN; Parry EM; Parry JM
    Mutat Res; 2001 Nov; 498(1-2):135-44. PubMed ID: 11673079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes.
    Cherpillod P; Amstad PA
    Mol Carcinog; 1995 May; 13(1):15-20. PubMed ID: 7766306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ras gene mutations in gastrointestinal cancers.
    Shen C; Chang JG; Lee LS; Yang MJ; Chen TC; Lin KY; Lee MD; Chen PH
    J Formos Med Assoc; 1991 Dec; 90(12):1149-54. PubMed ID: 1686883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism at codon 160 of human O6-methylguanine-DNA methyltransferase gene in young patients with adult type cancers and functional assay.
    Imai Y; Oda H; Nakatsuru Y; Ishikawa T
    Carcinogenesis; 1995 Oct; 16(10):2441-5. PubMed ID: 7586149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Mutations in human hepatocellular carcinomas from Germany.
    Kress S; Jahn UR; Buchmann A; Bannasch P; Schwarz M
    Cancer Res; 1992 Jun; 52(11):3220-3. PubMed ID: 1317262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.